A range of packages is available for industry partners to implement charity giving.
CPhI Worldwide has launched a new partnership with the international charity Global Angels in a move to encourage support from the pharmaceutical industry. Global Angels partners with innovative projects to deliver tangible, life-saving results in developing countries.
CPhI’s goal is to actively provide support and funds from the pharma industry to Global Angels. Pharma companies can help the charity through direct funding, volunteering, providing logistical support, or donating vital drugs to the developing world. According to CPhI, the initiative is already showing signs of success, with many companies registering their interest.
CPhI is offering two corporate social responsibility packages-“Angel Wings” and “Angel Logo”-that allow exhibitors or industry partners to get involved more quickly with Global Angels. The “Angel Wing”’ package is a direct charity funding initiative where donations from industry partners will be used to pay for cleft lip surgery, child food support, funding for a water well, or even help build a classroom or a rural hospital.
The “Angel Logo” program provides free advertising for any charity sponsor through CPhI’s global events portfolio. CPhI will provide advertising support to industry donors through a range of promotional options such as display and print advertising to live videos during the event, with a potential captive audience of 500,000 pharmaceutical professionals and industry press.
CPhI is encouraging exhibitors and visitors to contribute when booking their space or registering for the event. To find out more on how you or your business can help support this charity or to donate to Global Angels, please visit www.cphi.com/angels.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.